These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16804074)

  • 1. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.
    Samuel VT; Choi CS; Phillips TG; Romanelli AJ; Geisler JG; Bhanot S; McKay R; Monia B; Shutter JR; Lindberg RA; Shulman GI; Veniant MM
    Diabetes; 2006 Jul; 55(7):2042-50. PubMed ID: 16804074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
    Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
    Erion DM; Yonemitsu S; Nie Y; Nagai Y; Gillum MP; Hsiao JJ; Iwasaki T; Stark R; Weismann D; Yu XX; Murray SF; Bhanot S; Monia BP; Horvath TL; Gao Q; Samuel VT; Shulman GI
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11288-93. PubMed ID: 19549853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
    Zhu X; Wu YB; Zhou J; Kang DM
    Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
    Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
    Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
    Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.
    Liang Y; Osborne MC; Monia BP; Bhanot S; Watts LM; She P; DeCarlo SO; Chen X; Demarest K
    Metabolism; 2005 Jul; 54(7):848-55. PubMed ID: 15988691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.
    Souza Pauli LS; Ropelle EC; de Souza CT; Cintra DE; da Silva AS; de Almeida Rodrigues B; de Moura LP; Marinho R; de Oliveira V; Katashima CK; Pauli JR; Ropelle ER
    J Physiol; 2014 Mar; 592(6):1325-40. PubMed ID: 24396063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
    Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
    Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
    Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
    Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats.
    Huang W; Yu J; Jia X; Xiong L; Li N; Wen X
    Am J Chin Med; 2012; 40(4):721-33. PubMed ID: 22809027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.
    Matsumoto M; Han S; Kitamura T; Accili D
    J Clin Invest; 2006 Sep; 116(9):2464-72. PubMed ID: 16906224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity.
    Nakae J; Cao Y; Daitoku H; Fukamizu A; Ogawa W; Yano Y; Hayashi Y
    J Clin Invest; 2006 Sep; 116(9):2473-83. PubMed ID: 16917544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
    Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
    Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.